1. Clofazimine should be used in all cases of leprosy, says Indian research council
- Author
-
Soumyadeep Bhaumik
- Subjects
Riminophenazine ,medicine.medical_specialty ,business.industry ,medicine.drug_class ,Antibiotics ,General Medicine ,Dapsone ,medicine.disease ,Dermatology ,Surgery ,Clofazimine ,Regimen ,Research council ,medicine ,Leprosy ,business ,Rifampicin ,medicine.drug - Abstract
Clofazimine should be added to the regimen of drugs used to treat paucibacillary leprosy, the Indian Council of Medical Research has recommended.1 Clofazimine is a lipophilic riminophenazine antibiotic with antibacterial and anti-inflammatory properties. The latest recommendation from the Indian Council of Medical Research is based on a review it conducted on published data that showed that clofazimine “can be safely used . . . along with dapsone and rifampicin for the 6 month multidrug therapy (MDT) being used in the treatment of paucibacillary leprosy.” India achieved …
- Published
- 2013